Advertisement

Citation tools

Wayne, Alan S. et al "Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia." Blood 130.14 (2017): 1620-1627. Web. 22 Oct. 2017.